Search

Vertex COO Stuart Arbuckle on the approval and launch of CASGEVY for sickle cell disease at #ASH23
Stuart Arbuckle describes the approval and launch dynamics of this gene-edited cell therapy.
Dec 10, 2023
Also look for unique social pages for BiotechTV U.
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.